American Association for Cancer Research

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Lewis
    Lewis
  3. Morris
    Morris
  4. O'Donoghue
    O'Donoghue
  5. Zanzonico
    Zanzonico
  6. Solit
    Solit
  7. Hudis
    Hudis
  8. Schoder
    Schoder
  9. Slovin
    Slovin
  10. Blasberg
    Blasberg

Groups

  1. Molecular Imaging and Therapy Service (120)
  2. Radiology, Department of (117)
  3. GSK Faculty (90)
  4. Department of Medicine (75)
  5. Sloan Kettering Institute Faculty (67)
  6. Solid Tumor Oncology Division (67)
  7. Molecular Pharmacology and Chemistry Program Faculty (66)
  8. Sloan Kettering Institute Postdocs (38)
  9. Genitourinary Oncology Service (36)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (34)
Search Within
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (70)
  2. Meeting Abstract (45)
  3. Conference Paper (4)
  4. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (120)
  2. Radiology, Department of (117)
  3. GSK Faculty (90)
  4. Department of Medicine (75)
  5. Sloan Kettering Institute Faculty (67)
  6. Solid Tumor Oncology Division (67)

More Groups

People
  1. Steven Larson (63)
  2. Howard Scher (21)
  3. Neeta Pandit-Taskar (16)
  4. Jason Lewis (13)
  5. Michael Morris (12)
  6. Ronald Finn (11)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (6)
  4. 2021 (10)
  5. 2020 (7)
  6. 2019 (8)

More Years

Publications
  1. Clinical Cancer Research (61)
  2. Cancer Research (59)

Results (120)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: